JPRN-UMIN000014951已完成未知
The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients - The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
We terminated trial with no registered cases.There are two reasons for discontinuation. 1)Decreasing of candidate cases by the change of operating methods and postoperative management (many cases go back to ward directly without monitoring by artery-line that can use as blood sampling line) 2)By enactment of Clinical Trials Act, the usage restriction of oxycodone in this study arise (the possibility for regarding usage as Off-label use)
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Difficult patient to obtain consent or judge efficacy by mental disease or symptom. 2.Contrradicated cases for oxycodene hydrochloride (severe respiratory supression, COPD, heart failure, asthma attack, ileus, diarrhea). 3.The value of Hb is under 8mg/dl when the patient entersj intensive care unit. 4.The patient is judged to require blood transfusion after operation. 5.Also, the doctor determine the patient is inadequate to attend the study.
研究者
相似试验
已完成
2 期
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190099Takimoto Rishu40
已完成
不适用
Study for necessity of insulin treatment in two enteral feeding formulas which are different in carbohydrates and fatty acids concentrations in tube-fed subjects with type 2 diabetes mellitustype 2 diabetes mellitus, Cerebral vascular diseaseJPRN-UMIN000001784Saiseikai Central Hospital40
